Blockchain Registration Transaction Record

Boston BioLife to Co-Present Translational Longevity Summit in 2026

Boston BioLife and Healthspan Action Coalition will host the Translational Longevity Summit on Oct 7-11, 2026, at Harvard, uniting science, medicine, and policy.

The Translational Longevity Summit arrives at a critical moment for longevity medicine, where scientific breakthroughs in aging, healthspan, and regenerative medicine are accelerating but often struggle to reach patients due to regulatory, educational, and collaborative gaps. By uniting researchers, clinicians, patients, policymakers, and investors, the summit aims to create a shared framework for responsible translation—turning promising discoveries into measurable clinical progress. Boston BioLife’s decade-long focus on bridging science and clinical practice, now amplified through this high-profile event at Harvard’s Enterprise Research Campus, signals a growing recognition that solving aging-related diseases requires not just innovation but also education, patient safety, and cross-sector dialogue. For anyone invested in the future of healthcare, this summit represents a step toward making longevity science accessible, ethical, and effective for real-world patients.